N Miyokawa Selected Research

N Miyokawa Research Topics

2	Neoplasms (Cancer) 05/2000 - 04/2000
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Carcinogenesis 01/2017
1	Small Cell Carcinoma 11/2010
1	Adenocarcinoma 07/2001
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2001
1	Spontaneous Rupture 05/2001
1	Amyloidosis 05/2001
1	Idiopathic Pulmonary Fibrosis 05/2001
1	Shock 05/2001
1	Lung Diseases (Lung Disease) 05/2001
1	Autoimmune Diseases (Autoimmune Disease) 06/2000
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2000
1	Lymphangioma (Cavernous Lymphangioma) 04/2000
1	Hypoproteinemia 04/2000
1	Nephrotic Syndrome (Syndrome, Nephrotic) 03/2000
1	Proteinuria 03/2000
1	Pathologic Complete Response 03/2000
1	Esophageal Neoplasms (Esophageal Cancer) 02/2000

2	Proteins (Proteins, Gene)FDA Link 05/2000 - 04/2000
1	Aligeron (AS 2)IBA 01/2017
1	LipidsIBA 01/2017
1	GATIBA 07/2001
1	CarbohydratesIBA 07/2001
1	Codon (Codons)IBA 07/2001
1	Insulin (Novolin)FDA Link 07/2001
1	MucinsIBA 07/2001
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 07/2001
1	Amyloid (Amyloid Fibrils)IBA 05/2001
1	Protein Subunit VaccinesIBA 06/2000
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2000
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 06/2000
1	Peptides (Polypeptides)IBA 06/2000
1	AutoantigensIBA 06/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2000
1	ErbB Receptors (EGF Receptor)IBA 05/2000
1	Serum AlbuminIBA 04/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2000
1	Enalapril FDA LinkGeneric 03/2000
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2000
1	Prednisolone (Predate)FDA LinkGeneric 03/2000
1	nedaplatinIBA 02/2000